Map4k1 Mouse 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of MAP4K1 mRNA CTD PMID:22206623 Map4k1 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA CTD PMID:17942748 Map4k1 Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MAP4K1 mRNA CTD PMID:17942748 Map4k1 Mouse 17beta-estradiol multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP4K1 mRNA CTD PMID:23094148 Map4k1 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA CTD PMID:17942748 Map4k1 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map4k1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP4K1 mRNA CTD PMID:34747641 Map4k1 Mouse 2-butoxyethanol decreases expression EXP 6480464 n-butoxyethanol results in decreased expression of MAP4K1 mRNA CTD PMID:19812364 Map4k1 Mouse 2-palmitoylglycerol increases expression ISO MAP4K1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MAP4K1 mRNA CTD PMID:37199045 Map4k1 Mouse 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of MAP4K1 gene CTD PMID:31683443 Map4k1 Mouse 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Am 580 results in decreased expression of MAP4K1 mRNA CTD PMID:16982809 Map4k1 Mouse 5-aza-2'-deoxycytidine affects expression ISO MAP4K1 (Homo sapiens) 6480464 Decitabine affects the expression of MAP4K1 mRNA CTD PMID:23300844 Map4k1 Mouse acetamide increases expression ISO Map4k1 (Rattus norvegicus) 6480464 acetamide results in increased expression of MAP4K1 mRNA CTD PMID:31881176 Map4k1 Mouse aflatoxin B1 increases methylation ISO MAP4K1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MAP4K1 gene and Aflatoxin B1 results in increased methylation of MAP4K1 intron CTD PMID:28458013 and PMID:30157460 Map4k1 Mouse Aflatoxin B2 alpha increases methylation ISO MAP4K1 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of MAP4K1 intron CTD PMID:30157460 Map4k1 Mouse alpha-Zearalanol increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Zeranol results in increased expression of MAP4K1 mRNA CTD PMID:35163327 Map4k1 Mouse antirheumatic drug decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MAP4K1 mRNA CTD PMID:24449571 Map4k1 Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MAP4K1 mRNA CTD PMID:21569818 and PMID:22610609 Map4k1 Mouse benzo[a]pyrene affects methylation ISO MAP4K1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAP4K1 intron and Benzo(a)pyrene affects the methylation of MAP4K1 promoter CTD PMID:27901495 and PMID:30157460 Map4k1 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAP4K1 mRNA CTD PMID:32417428 Map4k1 Mouse benzo[a]pyrene increases methylation ISO MAP4K1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of MAP4K1 exon CTD PMID:27901495 Map4k1 Mouse bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MAP4K1 mRNA CTD PMID:21318169 Map4k1 Mouse bis(2-ethylhexyl) phthalate decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of MAP4K1 mRNA CTD PMID:21318169 Map4k1 Mouse bisphenol A decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of MAP4K1 mRNA CTD PMID:25181051 Map4k1 Mouse buta-1,3-diene decreases expression EXP 6480464 1 and 3-butadiene results in decreased expression of MAP4K1 mRNA CTD PMID:29038090 Map4k1 Mouse cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAP4K1 mRNA CTD PMID:24982889 Map4k1 Mouse carbamazepine affects expression ISO MAP4K1 (Homo sapiens) 6480464 Carbamazepine affects the expression of MAP4K1 mRNA CTD PMID:25979313 Map4k1 Mouse carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon analog affects the expression of MAP4K1 mRNA CTD PMID:25554681 Map4k1 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of MAP4K1 mRNA CTD PMID:25554681 Map4k1 Mouse CGP 52608 multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP4K1 gene] CTD PMID:28238834 Map4k1 Mouse choline multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA CTD PMID:20938992 and PMID:33549593 Map4k1 Mouse cisplatin affects expression ISO MAP4K1 (Homo sapiens) 6480464 Cisplatin affects the expression of MAP4K1 mRNA CTD PMID:23300844 Map4k1 Mouse cisplatin multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAP4K1 mRNA CTD PMID:27392435 Map4k1 Mouse copper atom increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of MAP4K1 mRNA CTD PMID:26033743 Map4k1 Mouse copper(0) increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of MAP4K1 mRNA CTD PMID:26033743 Map4k1 Mouse crocidolite asbestos affects expression ISO MAP4K1 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of MAP4K1 mRNA CTD PMID:17331233 Map4k1 Mouse cyanocob(III)alamin multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA CTD PMID:33549593 Map4k1 Mouse dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAP4K1 mRNA CTD PMID:21041162 Map4k1 Mouse Dibutyl phosphate affects expression ISO MAP4K1 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of MAP4K1 mRNA CTD PMID:37042841 Map4k1 Mouse diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of MAP4K1 mRNA CTD PMID:14648872 Map4k1 Mouse dimethylarsinic acid decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Cacodylic Acid results in decreased expression of MAP4K1 mRNA CTD PMID:17720352 Map4k1 Mouse dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA CTD PMID:34876320 Map4k1 Mouse dorsomorphin multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA CTD PMID:27188386 Map4k1 Mouse entinostat increases expression ISO MAP4K1 (Homo sapiens) 6480464 entinostat results in increased expression of MAP4K1 mRNA CTD PMID:27188386 Map4k1 Mouse epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of MAP4K1 mRNA CTD PMID:35436446 Map4k1 Mouse folic acid multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA CTD PMID:20938992 and PMID:33549593 Map4k1 Mouse gentamycin increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of MAP4K1 mRNA CTD PMID:22061828 Map4k1 Mouse gentamycin decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of MAP4K1 mRNA CTD PMID:33387578 Map4k1 Mouse glycine betaine multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA CTD PMID:33549593 Map4k1 Mouse hydrazine decreases expression EXP 6480464 hydrazine results in decreased expression of MAP4K1 mRNA CTD PMID:15282401 Map4k1 Mouse hypochlorous acid decreases expression EXP 6480464 Hypochlorous Acid results in decreased expression of MAP4K1 mRNA CTD PMID:19376150 Map4k1 Mouse L-methionine multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA CTD PMID:20938992 and PMID:33549593 Map4k1 Mouse lead(0) decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Lead results in decreased expression of MAP4K1 mRNA CTD PMID:19921347 Map4k1 Mouse lidocaine increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Lidocaine results in increased expression of MAP4K1 mRNA CTD PMID:35283115 Map4k1 Mouse methyl methanesulfonate decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of MAP4K1 mRNA CTD PMID:23649840 Map4k1 Mouse methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA CTD PMID:34876320 Map4k1 Mouse methylmercury chloride decreases expression ISO MAP4K1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MAP4K1 mRNA CTD PMID:28001369 Map4k1 Mouse monosodium L-glutamate decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 Sodium Glutamate results in decreased expression of MAP4K1 mRNA CTD PMID:28954212 Map4k1 Mouse nickel atom increases expression ISO MAP4K1 (Homo sapiens) 6480464 Nickel results in increased expression of MAP4K1 mRNA CTD PMID:25583101 Map4k1 Mouse paracetamol decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of MAP4K1 mRNA CTD PMID:33387578 Map4k1 Mouse perfluorononanoic acid decreases expression ISO MAP4K1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of MAP4K1 mRNA CTD PMID:25812627 Map4k1 Mouse perfluorooctane-1-sulfonic acid decreases expression ISO MAP4K1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of MAP4K1 mRNA CTD PMID:25812627 Map4k1 Mouse perfluorooctanoic acid decreases expression ISO MAP4K1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of MAP4K1 mRNA CTD PMID:25812627 Map4k1 Mouse phenylmercury acetate decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of MAP4K1 mRNA CTD PMID:26272509 Map4k1 Mouse phenylmercury acetate multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA CTD PMID:27188386 Map4k1 Mouse pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAP4K1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of MAP4K1 mRNA] CTD PMID:19710929 and PMID:20059764 Map4k1 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MAP4K1 mRNA CTD PMID:20059764 and PMID:23811191 Map4k1 Mouse quercetin decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Quercetin results in decreased expression of MAP4K1 mRNA CTD PMID:15309432 Map4k1 Mouse SB 431542 multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA CTD PMID:27188386 Map4k1 Mouse silver atom increases expression EXP 6480464 Silver results in increased expression of MAP4K1 mRNA CTD PMID:27131904 Map4k1 Mouse silver(0) increases expression EXP 6480464 Silver results in increased expression of MAP4K1 mRNA CTD PMID:27131904 Map4k1 Mouse sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA CTD PMID:34876320 Map4k1 Mouse sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA CTD PMID:34876320 Map4k1 Mouse sotorasib multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA CTD PMID:36139627 Map4k1 Mouse starch multiple interactions ISO Map4k1 (Rattus norvegicus) 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of MAP4K1 mRNA] CTD PMID:27363782 Map4k1 Mouse sulfates multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [Soot co-treated with Sulfates] affects the methylation of MAP4K1 promoter CTD PMID:25395096 Map4k1 Mouse sulfates affects methylation ISO MAP4K1 (Homo sapiens) 6480464 Sulfates affects the methylation of MAP4K1 promoter CTD PMID:25395096 Map4k1 Mouse sunitinib increases expression ISO MAP4K1 (Homo sapiens) 6480464 Sunitinib results in increased expression of MAP4K1 mRNA CTD PMID:31533062 Map4k1 Mouse tamibarotene increases expression ISO MAP4K1 (Homo sapiens) 6480464 tamibarotene results in increased expression of MAP4K1 mRNA CTD PMID:17229644 Map4k1 Mouse tetrachloromethane decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of MAP4K1 mRNA CTD PMID:31150632 Map4k1 Mouse thimerosal decreases expression ISO MAP4K1 (Homo sapiens) 6480464 Thimerosal results in decreased expression of MAP4K1 mRNA CTD PMID:27188386 Map4k1 Mouse thioacetamide increases expression ISO Map4k1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of MAP4K1 mRNA CTD PMID:34492290 Map4k1 Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MAP4K1 mRNA CTD PMID:23557971 Map4k1 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of MAP4K1 mRNA CTD PMID:27760801 Map4k1 Mouse trametinib multiple interactions ISO MAP4K1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA CTD PMID:36139627 Map4k1 Mouse triphenyl phosphate decreases expression ISO Map4k1 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of MAP4K1 mRNA CTD PMID:30589522 Map4k1 Mouse valproic acid affects expression ISO MAP4K1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP4K1 mRNA CTD PMID:25979313 Map4k1 Mouse valproic acid increases expression ISO MAP4K1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP4K1 mRNA CTD PMID:37505509 Map4k1 Mouse valproic acid increases methylation ISO MAP4K1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of MAP4K1 gene CTD PMID:29154799 Map4k1 Mouse zinc atom multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA CTD PMID:33549593 Map4k1 Mouse zinc(0) multiple interactions EXP 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA CTD PMID:33549593